An exciting new chapter is on the horizon for Phacilitate, following the announcement that Clarion Events, the global events business behind Phacilitate, is to be acquired by Informa, one of the world’s leading international B2B events, digital services and specialist knowledge groups.
For Phacilitate, this marks an exciting new chapter, creating new opportunities for further growth, strengthening our content and connections, engaging new audiences and continuing to evolve the value we bring to the advanced therapies industry.
For our customers, partners and community, it remains very much business as usual, with the same team, events and commitment to serving the advanced therapies industry.
Building on More Than 20 Years of Connecting the Industry
For more than two decades, Phacilitate has been bringing together the people, ideas and organisations driving the advanced therapies industry forward. Through our events, thought leadership, content and year-round industry engagement, we've built a global community dedicated to advancing the sector.
Becoming part of Informa will provide access to greater international reach, resources and expertise, giving us the opportunity to build on everything we've established while continuing to serve the industry that has always been at the heart of Phacilitate.
It's an opportunity to strengthen what makes Phacilitate distinctive, expand our connections across the global advanced therapies ecosystem and create even more value for the community we've spent over 20 years building.
Looking Ahead to 2027
And there's already plenty to look forward to.
Advanced Therapies Week returns to San Diego, 18–21 January 2027, bringing the global advanced therapies community together for another four days of connection, collaboration and industry insight.
This will be followed by Advanced Therapies Europe in Barcelona, 6–8 September 2027, as we continue to strengthen connections and drive conversations across the European advanced therapies landscape.
Our team is already hard at work developing both events, alongside our year-round programme of content, conversations and community initiatives.
As we look towards this next chapter, our focus remains unchanged: connecting the people and organisations shaping the future of advanced therapies.
An Exciting Future for Phacilitate
Kim Barnes, President, Phacilitate, said:
“This is an incredibly exciting moment for Phacilitate. We’ve spent more than two decades building a community and platform dedicated to advancing this industry, and joining Informa gives us an opportunity to think even bigger about what comes next.
With greater international reach, resources and capabilities behind us, we can build on everything that makes Phacilitate distinctive while creating even more opportunities for our customers, partners and community.
Our plans for 2027 are already well underway, and our customers, partners and community can expect the same commitment, focus and passion from the Phacilitate team as we enter this next phase. We’re excited not only about what’s ahead for Advanced Therapies Week and Advanced Therapies Europe, but about how we can continue growing Phacilitate as a year-round platform for the global advanced therapies industry.”
The Next Chapter Starts Here
We're proud of the community we've built and the role Phacilitate continues to play in connecting and advancing the global advanced therapies industry.
While this announcement signals an exciting opportunity for the future, our commitment to our customers, partners and community remains as strong as ever.
We're looking forward to building on what makes Phacilitate special and exploring the opportunities this next chapter could bring.
The proposed acquisition of Clarion Events by Informa remains subject to customary regulatory approvals and closing conditions.
)